Delivery Order SPE2DB22D2005-SPE2DB24FJNC6
- Not listed
- This federal contract award, valued at $1,067.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price, for the supply of IPOL VIAL 5ML medical products. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of IPOL VIAL 5ML medical supplies, with a ceiling value of $2,021.36 and a period of performance through May 23, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 4564628204 IPOL VIAL 5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $10,673.50, and an ultimate completion date of May 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.80 firm fixed price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,976.00 firm-fixed-price delivery order is for the provision of a specific medical item, identified as "IPOL VIAL 5ML." The contract has an ultimate completion date of August 28, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This federal contract award is a delivery order worth $20,920.06 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of IPOL VIAL 5ML medical supplies with a performance period through September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $3,724.20 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4556381777 IPOL VIAL 5ML, a pharmaceutical product, with a completion date of February 28, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4566582445 IPOL VIAL 5ML. The firm-fixed-price contract has a ceiling value of $33,571.25 and a completion date of December 3, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,371.20 firm fixed-price delivery order contract is for the supply of IPOL VIAL 5ML medical products, with a completion date of February 24, 2023. This contract is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,119.02 firm-fixed-price delivery order is for the supply of 4567327713 IPOL VIAL 5ML medical products, with a final completion date of February 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJNC6Delivery Order
This federal contract award, valued at $1,494.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IPOL VIAL 5ML. The contract has a ceiling value of $1,494.29 and is a Delivery Order placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award does not have a set-aside designation and was issued on a full and open competition basis, reflecting AmerisourceBergen's competitive position in the federal pharmaceutical supply market. The contract has a completion date of May 31, 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/30/24 |